vs

Side-by-side financial comparison of Ceribell, Inc. (CBLL) and Claros Mortgage Trust, Inc. (CMTG). Click either name above to swap in a different company.

Claros Mortgage Trust, Inc. is the larger business by last-quarter revenue ($46.7M vs $24.8M, roughly 1.9× Ceribell, Inc.). Ceribell, Inc. runs the higher net margin — -54.6% vs -468.9%, a 414.4% gap on every dollar of revenue.

Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.

Claros Mortgage Trust, Inc. is a U.S.-based real estate investment trust that invests in diversified mortgage-related assets, including residential and commercial mortgage loans and mortgage-backed securities. It pursues stable, risk-adjusted long-term returns for shareholders via rigorous asset evaluation and active portfolio management.

CBLL vs CMTG — Head-to-Head

Bigger by revenue
CMTG
CMTG
1.9× larger
CMTG
$46.7M
$24.8M
CBLL
Higher net margin
CBLL
CBLL
414.4% more per $
CBLL
-54.6%
-468.9%
CMTG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CBLL
CBLL
CMTG
CMTG
Revenue
$24.8M
$46.7M
Net Profit
$-13.5M
$-219.2M
Gross Margin
87.3%
Operating Margin
-58.9%
Net Margin
-54.6%
-468.9%
Revenue YoY
-22.4%
Net Profit YoY
-117.7%
EPS (diluted)
$-0.35
$-1.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBLL
CBLL
CMTG
CMTG
Q4 25
$24.8M
$46.7M
Q3 25
$22.6M
$46.1M
Q2 25
$21.2M
$51.6M
Q1 25
$20.5M
$43.4M
Q4 24
$60.2M
Q3 24
$17.2M
$64.9M
Q2 24
$64.5M
Q1 24
$58.8M
Net Profit
CBLL
CBLL
CMTG
CMTG
Q4 25
$-13.5M
$-219.2M
Q3 25
$-13.5M
$-9.5M
Q2 25
$-13.6M
$-181.7M
Q1 25
$-12.8M
$-78.6M
Q4 24
$-100.7M
Q3 24
$-10.4M
$-56.2M
Q2 24
$-11.6M
Q1 24
$-52.8M
Gross Margin
CBLL
CBLL
CMTG
CMTG
Q4 25
87.3%
Q3 25
88.3%
Q2 25
88.1%
Q1 25
87.9%
Q4 24
Q3 24
87.3%
Q2 24
Q1 24
Operating Margin
CBLL
CBLL
CMTG
CMTG
Q4 25
-58.9%
Q3 25
-64.8%
Q2 25
-70.5%
Q1 25
-69.3%
Q4 24
Q3 24
-57.8%
Q2 24
Q1 24
Net Margin
CBLL
CBLL
CMTG
CMTG
Q4 25
-54.6%
-468.9%
Q3 25
-59.6%
-20.7%
Q2 25
-64.4%
-351.9%
Q1 25
-62.4%
-181.3%
Q4 24
-167.2%
Q3 24
-60.6%
-86.7%
Q2 24
-17.9%
Q1 24
-89.7%
EPS (diluted)
CBLL
CBLL
CMTG
CMTG
Q4 25
$-0.35
$-1.56
Q3 25
$-0.37
$-0.07
Q2 25
$-0.38
$-1.30
Q1 25
$-0.36
$-0.56
Q4 24
$-0.72
Q3 24
$-1.85
$-0.40
Q2 24
$-0.09
Q1 24
$-0.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBLL
CBLL
CMTG
CMTG
Cash + ST InvestmentsLiquidity on hand
$159.3M
$173.2M
Total DebtLower is stronger
$3.2B
Stockholders' EquityBook value
$155.3M
$1.5B
Total Assets
$195.8M
$4.7B
Debt / EquityLower = less leverage
2.06×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBLL
CBLL
CMTG
CMTG
Q4 25
$159.3M
$173.2M
Q3 25
$168.5M
$339.5M
Q2 25
$177.4M
$209.2M
Q1 25
$182.7M
$127.8M
Q4 24
$99.1M
Q3 24
$14.1M
$113.9M
Q2 24
$148.2M
Q1 24
$232.5M
Total Debt
CBLL
CBLL
CMTG
CMTG
Q4 25
$3.2B
Q3 25
$3.7B
Q2 25
$4.0B
Q1 25
$4.7B
Q4 24
$4.9B
Q3 24
$5.1B
Q2 24
$5.3B
Q1 24
$5.5B
Stockholders' Equity
CBLL
CBLL
CMTG
CMTG
Q4 25
$155.3M
$1.5B
Q3 25
$164.1M
$1.7B
Q2 25
$172.2M
$1.8B
Q1 25
$180.9M
$1.9B
Q4 24
$2.0B
Q3 24
$-136.0M
$2.1B
Q2 24
$2.2B
Q1 24
$2.2B
Total Assets
CBLL
CBLL
CMTG
CMTG
Q4 25
$195.8M
$4.7B
Q3 25
$199.5M
$5.4B
Q2 25
$207.7M
$5.8B
Q1 25
$213.5M
$6.7B
Q4 24
$7.0B
Q3 24
$47.1M
$7.3B
Q2 24
$7.6B
Q1 24
$7.8B
Debt / Equity
CBLL
CBLL
CMTG
CMTG
Q4 25
2.06×
Q3 25
2.09×
Q2 25
2.29×
Q1 25
2.42×
Q4 24
2.44×
Q3 24
2.44×
Q2 24
2.46×
Q1 24
2.47×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBLL
CBLL
CMTG
CMTG
Operating Cash FlowLast quarter
$-10.8M
$-30.5M
Free Cash FlowOCF − Capex
$-11.0M
FCF MarginFCF / Revenue
-44.2%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-41.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBLL
CBLL
CMTG
CMTG
Q4 25
$-10.8M
$-30.5M
Q3 25
$-11.1M
$8.8M
Q2 25
$-7.5M
$-5.8M
Q1 25
$-11.4M
$-35.8M
Q4 24
$84.5M
Q3 24
$39.2M
Q2 24
$5.5M
Q1 24
$21.5M
Free Cash Flow
CBLL
CBLL
CMTG
CMTG
Q4 25
$-11.0M
Q3 25
$-11.5M
Q2 25
$-7.6M
Q1 25
$-11.6M
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
CBLL
CBLL
CMTG
CMTG
Q4 25
-44.2%
Q3 25
-50.8%
Q2 25
-35.9%
Q1 25
-56.4%
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
CBLL
CBLL
CMTG
CMTG
Q4 25
0.7%
Q3 25
1.6%
Q2 25
0.3%
Q1 25
0.7%
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBLL
CBLL

Products$18.8M76%
Subscription$6.0M24%

CMTG
CMTG

Real Estate Owned Portfolio$34.2M73%
Other$11.1M24%
Mixed Use Property Fixed Rents$1.4M3%

Related Comparisons